PDGFRB and neoplasm: Survival curves indicated that the proportion of CK19 + ID3 + tumor cells (P = 0.016) and CK19-PDGFRβ + cells (P = 0.005) both significantly correlated with poor prognosis in iCCApps (Fig. 6e).